Literature DB >> 11570936

Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome.

R Fass1, G F Longstreth, M Pimentel, S Fullerton, S M Russak, C F Chiou, E Reyes, P Crane, G Eisen, B McCarberg, J Ofman.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) presents a significant diagnostic and management challenge for primary care practitioners. Improving the accuracy and timeliness of diagnosis may result in improved quality and efficiency of care.
OBJECTIVE: To systematically appraise the existing diagnostic criteria and combine the evidence with expert opinion to derive evidence- and consensus-based guidelines for a diagnostic approach to patients with suspected IBS.
METHODS: We performed a systematic literature review (January 1966-April 2000) of computerized bibliographic databases. Articles meeting explicit inclusion criteria for diagnostic studies in IBS were subjected to critical appraisal, which formed the basis of guideline statements presented to an expert panel. To develop a diagnostic algorithm, an expert panel of specialists and primary care physicians was used to fill in gaps in the literature. Consensus was developed using a modified Delphi technique.
RESULTS: The systematic literature review identified only 13 published studies regarding the effectiveness of competing diagnostic approaches for IBS, the accuracy of diagnostic tests, and the internal validity of current diagnostic symptom criteria. Few studies met accepted methodological criteria. While symptom criteria have been validated, the utility of endoscopic and other diagnostic interventions remains unknown. An analysis of the literature, combined with consensus from experienced clinicians, resulted in the development of a diagnostic algorithm relevant to primary care that emphasizes a symptom-based diagnostic approach, refers patients with alarm symptoms to subspecialists, and reserves radiographic, endoscopic, and other tests for referral cases. The resulting algorithm highlights the reliance on symptom criteria and comprises a primary module, 3 submodules based on the predominant symptom pattern (constipation, diarrhea, and pain) and severity level, and a subspecialist referral module.
CONCLUSIONS: The dearth of available evidence highlights the need for more rigorous scientific validation to identify the most accurate methods of diagnosing IBS. Until such time, the diagnostic algorithm presented herein could inform decision making for a range of providers caring for primary care patients with abdominal discomfort or pain and altered bowel function suggestive of IBS.

Entities:  

Mesh:

Year:  2001        PMID: 11570936     DOI: 10.1001/archinte.161.17.2081

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  Questionnaire on Irritable Bowel Syndrome and Symptom Management Among Endurance Athletes Is Valid and Reliable.

Authors:  Lauren A Killian; Karen M Chapman-Novakofski; Soo-Yeun Lee
Journal:  Dig Dis Sci       Date:  2018-09-19       Impact factor: 3.199

2.  Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.

Authors:  J Hammer; G D Eslick; S C Howell; E Altiparmak; N J Talley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

3.  Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome.

Authors:  Gerard Clarke; Peter Fitzgerald; Alan A Hennessy; Eugene M Cassidy; Eamonn M M Quigley; Paul Ross; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

Review 4.  New developments in the diagnosis and treatment of irritable bowel syndrome.

Authors:  George F Longstreth; Douglas A Drossman
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 5.  Tegaserod: a review of its use in the management of irritable bowel syndrome with constipation in women.

Authors:  Antona J Wagstaff; James E Frampton; Katherine F Croom
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Irritable bowel syndrome: physicians' awareness and patients' experience.

Authors:  Linda Bjork Olafsdottir; Hallgrímur Gudjonsson; Heidur Hrund Jonsdottir; Jon Steinar Jonsson; Einar Bjornsson; Bjarni Thjodleifsson
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

7.  Knowledge, attitudes, and practices of primary care physicians about irritable bowel syndrome in Northern Saudi Arabia.

Authors:  Ahmad H Al-Hazmi
Journal:  Saudi J Gastroenterol       Date:  2012 May-Jun       Impact factor: 2.485

Review 8.  Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date.

Authors:  Wathsala S Nanayakkara; Paula Ml Skidmore; Leigh O'Brien; Tim J Wilkinson; Richard B Gearry
Journal:  Clin Exp Gastroenterol       Date:  2016-06-17

Review 9.  Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials.

Authors:  Jun Li; Wenhua Zhu; Wenhui Liu; Yingqiao Wu; Benyan Wu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

10.  Gastrointestinal Symptoms and FODMAP Intake of Aged-Care Residents from Christchurch, New Zealand.

Authors:  Wathsala S Nanayakkara; Richard B Gearry; Jane G Muir; Leigh O'Brien; Tim J Wilkinson; Jonathan A Williman; Paula M L Skidmore
Journal:  Nutrients       Date:  2017-09-29       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.